Brett Casper

About Brett Casper

Brett is an experienced life sciences strategy consultant whose work combines deep subject matter expertise and rigorous data-driven analytics / insights. His primary area of specialization is product commercialization, with a specific focus on market access (such as channel, patient services, pricing and contracting, etc.). Brett’s work primarily spans the specialty lite, specialty, and orphan / rare product archetypes.Brett\'s primary areas of expertise include: Product Launch Strategy, Orphan / Rare, Specialty (Self- and HCP-Admin), Specialty Lite, Buy and Bill Commercialization, Medical Benefit Pricing / Contracting, ASP Stewardship, Government Pricing, Gross-to-Net Optimization, Distribution, Specialty Pharmacy, Specialty Infusion Providers, Patient and Provider Services, Field / Customer-Facing Support, and Emergency Use Authorization.

Experience

1. Senior Principal Consultant (Associate Partner)

   Blue Fin Group, An Integrichain Company

   Jan 2025 — Present · Columbus, OH, US

   Day-to-Day Responsibilities: Owns all aspects of the project lifecycle, from opportunity identification through project delivery Establish and maintain client relationships at the Director, Executive Director, or Vice President levels Manage consulting teams with a size from two to five associates (depending on a project’s scope) Serve as professional development manager for one consultant-level associateKey Achievements in 2024: Sold ~$2.1 million in project work across seven clients Leading a team that has displaced McKinsey as a “go-to” strategic advisor at a top-3 manufacturer Average delivery margin of >10% on all projects managed Serving as the firm’s director of the “Product Strategy” verticalSample Projects Sold and Delivered in 2024: Redesign of top-3 pharma manufacturer’s entire patient support model / capabilities Revise and optimize commercialization strategy for a small biotech preparing to launch into a new indication for its flagship HCP-administered product Assessment of optimal vial size and configuration for an emerging manufacturer to minimize wastage rebates owed to Medicare due to the REFUND Act Design of a highly sophisticated channel strategy for a small biotech preparing for launch of its first HCP-administered product which requires use of a medical device

Education

• New York University

  Master of Arts (M.A.)

  2007 — 2009

• Cedarville University

  Bachelor of Arts (B.A.)

  2002 — 2007

• New York University

  Doctor of Philosophy (PhD)

  2009 — 2015

Skills

• Qualitative Research
• Oncology
• Communication
• Political Economy
• Time Series Analysis
• Research Design
• Economics
• International Relations
• Survey Research
• Quantitative Research
• Microsoft Excel
• Powerpoint
• Logistic Regression
• Comparative Politics
• International Development
• Data Modeling
• Stata Programming
• Microsoft Outlook
• Regression Analysis
• Analytical Writing
• Management Consulting
• Data Analysis
• Segmentation
• Latex
• Cluster Analysis
• Survival Analysis
• Political Science
• Decision Trees
• Econometrics
• Marketing Strategy
• International Political Economy
• Marketing
• Virology
• Secondary Data Analysis
• Linear Regression
• Pharmaceutical Industry
• Statistics
• International Trade
• Research
• Market Research